Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-K stay in one workspace.
RCKT
$2.20
-5.92%
RCKT
· Rocket Pharmaceuticals, Inc.
$2.20
-0.14 (-5.92%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$256.87M
Shares
109.77M
Volume · Oct 21
2.02M
Avg daily vol (3M)
1.78M
All webcasts
Earnings call · FY2025 Q4
Rocket Pharmaceuticals, Inc. (RCKT) Q4 2025 Earnings Call
Revenue · derived Q4
$0
Net income · derived Q4
-$42.54M
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 26, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 26, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Mar 27, 2026 · complete as-filed document